Jiyang Yu Selected Research

Jiyang Yu Research Topics

Disease

25	Neoplasms (Cancer) 07/2024 - 08/2015
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 07/2016
8	Leukemia 04/2024 - 01/2020
6	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 12/2013
4	Medulloblastoma 10/2023 - 01/2020
4	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2015
3	Neuroblastoma 01/2024 - 01/2018
2	Adenocarcinoma 07/2024 - 08/2015
2	Hepatoblastoma 01/2023 - 01/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2016
2	Glucocorticoid Receptor Deficiency 01/2020 - 12/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2024
1	Starvation 11/2023
1	Genomic Instability 10/2023
1	Cognitive Dysfunction 10/2023
1	Turcot syndrome 01/2023
1	Carcinogenesis 01/2023
1	Neurofibrosarcoma (MPNST) 11/2022
1	Neoplasm Metastasis (Metastasis) 11/2022
1	Sarcoma (Soft Tissue Sarcoma) 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 05/2019
1	Liver Diseases (Liver Disease) 05/2019
1	Epstein-Barr Virus Infections 01/2019
1	Infections 01/2019
1	Hypoxia (Hypoxemia) 11/2015

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2013
3	EnzymesIBA 07/2024 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2023 - 03/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2016
3	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2022
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2018
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
2	Asparaginase (Elspar)FDA Link 04/2024 - 01/2022
2	CytokinesIBA 11/2023 - 01/2022
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2023 - 01/2023
2	ribociclibIBA 01/2023 - 01/2022
2	Drug CombinationsIBA 01/2023 - 01/2020
2	Gemcitabine FDA Link 01/2022 - 01/2021
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2016
2	PlatinumIBA 01/2022 - 05/2016
2	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021 - 01/2021
2	talazoparibIBA 11/2021 - 01/2021
2	venetoclaxIBA 01/2021 - 01/2020
2	Hormones (Hormone)IBA 01/2020 - 08/2015
2	MK 2206IBA 01/2020 - 12/2013
2	Phosphotransferases (Kinase)IBA 08/2015 - 12/2013
1	Glucose (Dextrose)FDA LinkGeneric 07/2024
1	Cytochrome P-450 CYP3AIBA 07/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2024
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2023
1	AntigensIBA 11/2023
1	Interleukin-10 ReceptorsIBA 11/2023
1	Amyloid (Amyloid Fibrils)IBA 10/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2023
1	ricolinostatIBA 01/2023
1	Retinoblastoma ProteinIBA 01/2023
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2023
1	MTOR InhibitorsIBA 01/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023
1	Oleanolic AcidIBA 01/2023
1	2-mercaptopurineIBA 01/2023
1	blinatumomabIBA 12/2022
1	NestinIBA 11/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	GlutaminaseIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	thiazolyl blueIBA 01/2022
1	IACS-010759IBA 01/2022
1	gilteritinibIBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	CateninsIBA 12/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Topoisomerase I InhibitorsIBA 11/2021
1	GANT 61IBA 01/2021
1	Decitabine FDA Link 01/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020
1	AntioxidantsIBA 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 01/2020
1	SilymarinIBA 05/2019
1	ElementsIBA 01/2018
1	Ribosomal Protein S6IBA 07/2016
1	CalcineurinIBA 07/2016
1	Hyaluronic Acid (Hyaluronan)IBA 11/2015
1	Growth InhibitorsIBA 11/2015

Therapy/Procedure

14	Therapeutics 04/2024 - 12/2013
9	Drug Therapy (Chemotherapy) 01/2023 - 11/2015
2	Immunotherapy 12/2019 - 06/2019
1	Aftercare (After-Treatment) 01/2022
1	Chemoradiotherapy 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2019